Oxford University researchers target previously unknown ‘genetic vulnerability’ in breast cancer cells
The study has uncovered a genetic vulnerability present in nearly 10% percent of all breast cancers tumors
The study has uncovered a genetic vulnerability present in nearly 10% percent of all breast cancers tumors
This novel system could offer financial protection from fluctuations in market prices or changes in demand, and mitigate risks associated with an unreliable climate
Discover the most groundbreaking recent advancements in PFAS analysis and take a look forward to the developments set to shape the future of the field
Abbott introduces two new offerings within its web-based laboratory information management systems, STARLIMS
AACC 2018 plenary speaker, Professor James Collins, provides an insight into the future of synthetic biology and CRISPR-based diagnostic tools
Huge turnout as industry leaders recognize the best in the business at the biggest ever Clinical Scientists’ Choice Awards in San Diego
Optimization of genetic analyses using digital PCR
National Cancer Institute-MATCH trial to sequence thousands of tumor samples using Ion Torrent targeted sequencing technology
Bertin Corp Solutions for Hard Sample Grinding
One of Absolute Antibody’s engineering services is the design and manufacture of multi-specific antibody formats. Starting with a hybridoma cell line or antibody sequence, we can deliver from milligrams to grams of your custom bispecific, 100% royalty-free. Customers can also mix-and-match targets from our extensive antibody catalog to build their own custom bispecific reagent.
A specialized and GxP-certified laboratory for Bioanalytical Service Solutions -with scientific expertise & advanced technologies. We offer assay development, validation, and sample analysis of pharmacokinetics, toxicokinetic, pharmacodynamics, immunogenicity, and biomarker analysis.